People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

4.33AUD
24 Dec 2014
Price Change (% chg)

$-0.04 (-0.92%)
Prev Close
$4.37
Open
$4.41
Day's High
$4.41
Day's Low
$4.30
Volume
32,219
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

O'Dwyer, Donal 

Brief Biography

Mr. Donal P. O'Dwyer, BE, MBA, is Non-Executive Director of Mesoblast Ltd. Donal O’Dwyer has over 25 years of experience as a senior executive in the global cardiovascular and medical devices industries. From 1996 to 2003, he worked for Cordis Cardiology, the cardiology division of Johnson & Johnson’s Cordis Corporation, initially as its President (Europe) and as its worldwide President from 2000. In his role, Mr O’Dwyer led Cordis through the launch of the revolutionary Cypher drug eluting coronary stent technology, and saw the company take over number one market share of coronary stents worldwide. Prior to joining Cordis, he worked for 12 years with Baxter Healthcare, rising from plant manager in Ireland to President of the Cardiovascular Group, Europe (now Edwards Lifesciences). Mr O’Dwyer is a qualified civil engineer and has an MBA. He has been Non-executive Director, Cochlear Limited (since 2005); Non-executive Director, Atcor Medical Holdings Limited (since 2004); and Non-executive Director, Fisher & Paykel Healthcare (since 2013). He was Non-executive Director, Sunshine Heart (from 2004 to 2013). He is Chairman of the Remuneration and Nomination Committee and Member of the Audit & Risk Committee.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks